Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-23876 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CEPT1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- This antibody is predicted to react with mouse, rat and Xenopus based on sequence homology.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 400 µL
- Concentration
- 0.5 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Metabolic control of T(FH) cells and humoral immunity by phosphatidylethanolamine.
Vacuole membrane protein 1 marks endoplasmic reticulum subdomains enriched in phospholipid synthesizing enzymes and is required for phosphoinositide distribution.
Fu G, Guy CS, Chapman NM, Palacios G, Wei J, Zhou P, Long L, Wang YD, Qian C, Dhungana Y, Huang H, Kc A, Shi H, Rankin S, Brown SA, Johnson A, Wakefield R, Robinson CG, Liu X, Sheyn A, Yu J, Jackowski S, Chi H
Nature 2021 Jul;595(7869):724-729
Nature 2021 Jul;595(7869):724-729
Vacuole membrane protein 1 marks endoplasmic reticulum subdomains enriched in phospholipid synthesizing enzymes and is required for phosphoinositide distribution.
Tábara LC, Vicente JJ, Biazik J, Eskelinen EL, Vincent O, Escalante R
Traffic (Copenhagen, Denmark) 2018 Aug;19(8):624-638
Traffic (Copenhagen, Denmark) 2018 Aug;19(8):624-638
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis using a CEPT1 polyclonal antibody (Product # PA5-23876) in HL-60 cell lysates (35 µg per lane).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis in formalin-fixed, paraffin-embedded human breast tissue using a CEPT1 polyclonal antibody (Product # PA5-23876), followed by HRP-conjugated secondary antibody and DAB staining.
